PMC:7600245 / 40824-41034 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T170","span":{"begin":177,"end":186},"obj":"Body_part"}],"attributes":[{"id":"A170","pred":"fma_id","subj":"T170","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"In this direction, selinexor and similar inhibitors have exhibited potent anti-inflammatory activity by suppressing the activation of NFkB and p38 signaling, leading to reduced cytokines in a variety of models."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T369","span":{"begin":92,"end":100},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T370","span":{"begin":120,"end":130},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T371","span":{"begin":147,"end":156},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T372","span":{"begin":190,"end":191},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"In this direction, selinexor and similar inhibitors have exhibited potent anti-inflammatory activity by suppressing the activation of NFkB and p38 signaling, leading to reduced cytokines in a variety of models."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T605","span":{"begin":41,"end":51},"obj":"Chemical"}],"attributes":[{"id":"A605","pred":"chebi_id","subj":"T605","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"In this direction, selinexor and similar inhibitors have exhibited potent anti-inflammatory activity by suppressing the activation of NFkB and p38 signaling, leading to reduced cytokines in a variety of models."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T65","span":{"begin":147,"end":156},"obj":"http://purl.obolibrary.org/obo/GO_0023052"}],"text":"In this direction, selinexor and similar inhibitors have exhibited potent anti-inflammatory activity by suppressing the activation of NFkB and p38 signaling, leading to reduced cytokines in a variety of models."}

{"project":"LitCovid-sentences","denotations":[{"id":"T307","span":{"begin":0,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In this direction, selinexor and similar inhibitors have exhibited potent anti-inflammatory activity by suppressing the activation of NFkB and p38 signaling, leading to reduced cytokines in a variety of models."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1222","span":{"begin":143,"end":146},"obj":"Gene"},{"id":"1233","span":{"begin":19,"end":28},"obj":"Chemical"}],"attributes":[{"id":"A1222","pred":"tao:has_database_id","subj":"1222","obj":"Gene:1432"},{"id":"A1233","pred":"tao:has_database_id","subj":"1233","obj":"MESH:C585161"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In this direction, selinexor and similar inhibitors have exhibited potent anti-inflammatory activity by suppressing the activation of NFkB and p38 signaling, leading to reduced cytokines in a variety of models."}